123i 5-ia
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00397696)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Payload
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 123i 5-ia
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00397696 | Phase 2 | Nov 1, 2006 | Department of Defense, Institute for Neurodegenerative Disorders |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 1 | 0 | 1 | 2006 |
| Institute for Neurodegenerative Disorders | Academic/Hospital | 1 | 1 | 1 | 2006 |
2 organizations
Page 1 / 1